Oxford Science Enterprises welcomes Kirsty Lloyd-Jukes as an Entrepreneur in Residence to accelerate company creation
April 18 2024 - 3:00AM
- An experienced entrepreneur, Kirsty is the former CEO of
Oxford spinout Latent Logic, which was acquired by world-leading
autonomous driving company Waymo in 2019
Oxford, UK: April 18, 2024: Oxford Science Enterprises
(OSE), the independent investment company created to found, fund
and build transformational businesses via its unique partnership
with the University of Oxford, today announces the appointment of
Kirsty Lloyd-Jukes as Entrepreneur in Residence (EIR) focused on
the creation of Deep Tech companies.
Kirsty has over ten years’ experience in entrepreneurship across
deep tech and consumer sectors with expertise in business
development and scaling, operations, and fundraising. Kirsty was
the CEO of Latent Logic, a spinout of Oxford University’s
Department of Computer Science employing state-of-the-art deep
learning to accelerate the development and scale out of autonomous
car technology. Latent Logic was acquired in 2019 by Alphabet
subsidiary Waymo, the world-leading autonomous driving technology
company.
Kirsty is a Mentor at Creative Destruction Lab, a seed-stage
incubator for scalable science and technology-based companies and
was a non-executive director at the Institute of Directors, a
business organisation founded to support entrepreneurship in the
UK.
Sam Harman, Acting Head of Deep Tech, said: “Kirsty
brings exceptional leadership and mentor qualities, combined with a
deep understanding of both the deep tech and investor landscapes.
We look forward to her insights and expertise as we continue to
uncover and build the next generation of innovative technology
companies.”
Kirsty Lloyd-Jukes added: “I am delighted to join Oxford
Science Enterprises as an Entrepreneur in Residence and look
forward to immersing myself in the breakthrough science and
technological innovation being advanced at Oxford University. I am
excited to work alongside OSE’s Deep Tech team, which has a strong
track record of creating and growing groundbreaking companies
tackling some of the world’s greatest challenges.”
OSE’s EIR programme brings seasoned entrepreneurs in-house to
accelerate its mission to uncover the most promising scientific and
technological innovations at Oxford and build them into
world-leading businesses. The programme has resulted in the
creation of innovative Oxford spinouts including neurology care
platform Neu Health, photonic chip company Salience Labs, and
neuromodulation company Amber Therapeutics.
OSE’s Deep Tech team is actively investing to address some of
humanity’s most pressing challenges. From artificial intelligence
and quantum computing to next generation herbicides, OSE is
dedicated to helping visionary entrepreneurs build businesses that
are transforming industries and become the next generation of
global leaders.
ENDS
About Oxford Science Enterprises
Oxford Science Enterprises (OSE) is an independent,
billion-pound investment company, created in 2015 to found, fund
and build transformational businesses via its unique partnership
with the University of Oxford, the world’s #1 research
university.
This partnership enables OSE to work with the brightest academic
minds tackling the world’s toughest challenges. In collaboration
with its global network of entrepreneurs and advisers, OSE goes
well beyond funding to shape and nurture these complex ideas into
successful businesses.
Actively focused on a core portfolio of around 40 companies
spanning three high-growth, high-impact sectors - Life Sciences,
Health Tech, and Deep Tech - the company adopts a flexible,
long-term investment approach, recognising the path from
ground-breaking research to global markets takes time and
resilience.
To date, OSE has invested £0.7 billion in over 80 ambitious
companies built on Oxford science. A key player in Oxford’s
entrepreneurial ecosystem, OSE is highly motivated to foster an
environment that catalyses pioneering research and steers it to
commercial success.
Find out more: oxfordscienceenterprises.com |
Twitter | LinkedIn
Contacts:
Oxford Science Enterprises
Claire LaRocca – media@oxfordsciences.com
For media enquiries:
Mark Swallow, Sandi Greenwood, Frazer Hall –
MEDiSTRAVA Consulting
oxfordsciences@medistrava.com
+44 (0)203 928 6900